News Focus
News Focus
icon url

capgain

03/24/14 5:49 PM

#90130 RE: **D*A** #90129

Thanks for that info and chart!
icon url

EZ2

03/24/14 6:05 PM

#90131 RE: **D*A** #90129

'sticky note'


Thx D*A
icon url

timhyma

03/24/14 10:08 PM

#90139 RE: **D*A** #90129

Damn, looking at UVE from the screener- I sold it at 4.49 last March, 2013.

Shoulda trusted the method, eh?


Universal Insurance Holdings Inc. (UVE) -NYSE ? Follow


14.32 Up 0.04(0.28%)
52-Week High (Mar 7, 2014)3: 15.34

I still see fair value around $15.50ish
icon url

timhyma

03/25/14 8:13 AM

#90165 RE: **D*A** #90129

This one looks interesting if you want in the S.A. Markets:
http://finance.yahoo.com/q?s=ELP

Did it break through resistance yesterday?
icon url

EZ2

04/07/14 9:15 AM

#90833 RE: **D*A** #90129

Mazor Robotics to Present at the Needham Healthcare Conference

BUSINESS WIRE 9:13 AM ET 04/07/14
Symbol Last Price Change
MZOR 20.67down 0 (0%)
QUOTES AS OF 04:00:00 PM ET 04/04/2014

CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd.(MZOR) , a developer of innovative guidance systems and complementary products, is scheduled to present at the 13th Annual Needham Healthcare Conference on Thursday, April 9, 2014 at 9:20am ET at the Westin Grand Central Hotel in NYC.

A live webcast and subsequent archived replay of the Company’s presentation may be accessed via the investor relations section of the Company’s website.

About Mazor

Mazor Robotics (MZOR) is dedicated to the development and marketing of innovative surgical guidance systems and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance®, is a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics(MZOR) systems have been successfully used in the placement of over 45,000 implants worldwide. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics(MZOR) technology. For more information, the content of which is not part of this press release, please visit www.mazorrobotics.com.



Source: Mazor Robotics Ltd.(MZOR)

Copyright Business Wire 2014
icon url

EZ2

04/11/14 7:08 AM

#90960 RE: **D*A** #90129

Gap shares down 3.9%, building on after-hours fall

MARKETWATCH 7:09 AM ET 04/11/14

(END) Dow Jones Newswires
04-11-140709ET
Copyright (c) 2014 Dow Jones & Company, Inc.
icon url

EZ2

04/18/14 6:34 AM

#91239 RE: **D*A** #90129

Blues beat Blackhawks 4-3 in 3 OTs
icon url

EZ2

04/22/14 7:43 AM

#91270 RE: **D*A** #90129

Arch Coal 1Q Loss/Shr 59c >ACI
icon url

EZ2

04/22/14 10:10 AM

#91284 RE: **D*A** #90129

The Daily Docket: Genco Enters Chapter 11 Bankruptcy -- WSJ Blog

DOW JONES & COMPANY, INC. 10:11 AM ET 04/22/14

Symbol Last Price Change

GM 34.21up +0.23 (+0.68%)

QUOTES AS OF 10:11:51 AM ET 04/22/2014

New York shipping tycoon Peter Georgiopoulos's Genco Shipping & Trading filed for Chapter 11 bankruptcy protection Monday, with a prepackaged restructuring plan that was hammered out with creditors and unveiled earlier this month. Read the Daily Bankruptcy Review article via The Wall Street Journal.

(Daily Bankruptcy Review is a daily newsletter with comprehensive coverage and analysis of emerging and in-progress insolvencies and turnarounds. For a two-week trial, visit our homepage , scroll to the bottom and click "try for free.")

General Motors Co. (GM) wants a judge to reaffirm an order freeing the car company from most liabilities, Bloomberg reports.

The Supreme Court on Monday declined to hear a dispute from the AMR Corp. bankruptcy over whether the former American Airlines parent owes its bondholders a penalty fee in connection with the prepayment of more than $1.3 billion in debt. The DBR article is available via WSJ.

A group of investors is appealing a federal judge's decision that certain repurchase agreements don't qualify for " customer status" in a failed brokerage business, as the banks' fight with Lehman Brothers Inc. over their claims continues. Read the DBR article in WSJ.

Mexican home builder Geo entered bankruptcy protection, Reuters reports.

Law Blog reports that ex-Dewey & LeBoeuf LLP partner John Altorelli might be a witness for the prosecution of three former leaders of the collapsed firm.

Write to Melanie Cohen at melanie.cohen@wsj.com . Follow her on Twitter at @MelanieLisa .

More at The Wall Street Journal's Bankruptcy Beat blog, http://blogs.wsj.com/bankruptcy/


(END) Dow Jones Newswires
04-22-141011ET
Copyright (c) 2014 Dow Jones & Company, Inc.
icon url

EZ2

04/23/14 7:30 AM

#91325 RE: **D*A** #90129

Plug Power shares sink on secondary stock offering

MARKETWATCH 7:32 AM ET 04/23/14
Symbol Last Price Change
PLUG 6.7down 0 (0%)
QUOTES AS OF 04:00:01 PM ET 04/22/2014

NEW YORK (MarketWatch) -- Shares of Plug Power Inc.(PLUG) slid 10% premarket Wednesday to $6.02 after the fuel-cell maker said it was partaking in a secondary offering of stock. The company will sell 15 million additional shares, according to a prospectus filed with the Securities and Exchange Commission. There is not yet any pricing information. The stock closed at $6.70 on Tuesday. The offering is being managed by Morgan Stanley and Barclays, and is co-managed by Cowen & Company and FBR Capital Markets.

-Ben Eisen; 415-439-6400; AskNewswires@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


(END) Dow Jones Newswires
04-23-140732ET
Copyright (c) 2014 Dow Jones & Company, Inc.
icon url

EZ2

04/23/14 8:49 AM

#91337 RE: **D*A** #90129

FB ---- after hours reporting ----- any guesses?

FTR: I'm saying they blow it out of the water!! ;-)
icon url

EZ2

05/16/14 2:02 PM

#92185 RE: **D*A** #90129

Bill Gross explains why Treasurys are rallying

MARKETWATCH 2:01 PM ET 05/16/14


NEW YORK (MarketWatch) -- The rally in U.S. Treasurys that pushed 10-year yields to their lowest level in nearly seven months reflects the likelihood that the Federal Reserve will keep rates low in a slowly growing global economy, according to Bill Gross, chief investment officer at Pimco.

The 10-year note (10_YEAR) yield, which falls as bond prices rise, dropped more than 15 basis points to 2.50% in the past three sessions. That move is emblematic of the way interest rates should behave as the world shifts toward the "new neutral" paradigm outlined by Pimco earlier this week, the bond market veteran told MarketWatch in emailed comments.

"2.50% currently reflects a 0.5% new neutral rate and seems fair for now," Gross said.

The new-neutral outlook published by Gross and Pimco adviser Richard Clarida suggests that the global economy is transforming from a period of recovery after the financial crisis -- termed the "new normal" back in 2009 -- toward stability that is characterized by modest economic growth over the next three-to-five years.

With economies expanding more slowly than they did prior to the financial crisis, central banks are likely to keep their key interest rates low, cushioning lending rates from a sharp rise. In the U.S., the fed funds rate is currently anchored near zero, with many traders expecting it to begin rising in the middle of next year. But Gross suggested yields will be dictated by how high the Fed eventually hikes rates. It may stop at a lower point than it did in past rate cycles.

"If the new neutral policy rate is 0% and the Fed achieves its 2% inflation target, then the 10-year Treasury should trade at close to 2%. However, because of the large uncertainty as to what the New Neutral rate should be, I would not expect it to trade there," the Pimco founder said.

Under his outlook, the Fed's nominal funds rate would top out somewhere near 2% in the coming years. That's a relatively small climb from the current rate of near zero.

Gross, whose flagship $230 billionPimco Total Return Fund (PTTRX) is the largest bond fund in the world, is among a growing group of investors and economists to suggest that the drop in bond yields since the beginning of the year reflects expectations of a lower Fed lending rate.

"Your perception of what yield level of the 10-year Treasury note represents value is a lot different if you think the fed funds rate is eventually going to peak at 2% than if you think the fed funds rate is eventually going to peak at 4% ," said Steve East, economist and strategist at Height Analytics, in a note to clients.

For its part, the Federal Reserve has said it could keep rates lower than is considered normal in the coming years. In the Fed's March statement, the policy committee wrote: "Even after employment and inflation are near mandate-consistent levels, economic conditions may, for some time, warrant keeping the target federal funds rate below levels the Committee views as normal in the longer run."

However, the longer-run expectations of central bank officials suggest the fed funds rate could drift higher toward 4% , intensifying discussions about where the rate's resting place will be.

The consensus forecast for average 10-year Treasury yields in 2015 is 3.6%, according to Blue Chip Economic Indicators.

More must-reads from MarketWatch:

It's Fed expectations that are pushing Treasury yields down

Goldstein: Economy improving faster than markets and Fed believe

Gayed: Treasury-bond market shows signs of fear, panic buying

-Ben Eisen; 415-439-6400; AskNewswires@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


(END) Dow Jones Newswires
05-16-141401ET
Copyright (c) 2014 Dow Jones & Company, Inc.
icon url

EZ2

05/21/14 4:17 PM

#92311 RE: **D*A** #90129

CS
icon url

EZ2

06/02/14 8:45 AM

#92731 RE: **D*A** #90129

U.S. futures imply flat open with indexes at record levels

REUTERS 8:44 AM ET 06/02/14
By Ryan Vlastelica

NEW YORK (Reuters) - U.S. stock index futures pointed to a flat open on Monday, with investors finding few reasons to keep pushing shares higher, with the Dow and S&P 500 at record levels.

Equities have been strong performers lately, with the Dow and S&P ending their fourth straight monthly rise in May and the Nasdaq up for its third straight week last week. However, those gains have recently come on anemic volume, a trend that looks to continue Monday, suggesting the rise lacks conviction.

Investors continue to watch the yield of the U.S. Treasury 10-year note, which remains near an 11-month low. Low yields could help boost dividend-paying stocks, including in the telecom and utility sectors.

The CBOE Volatility index continues to hover around lows not seen since March 2013. That the so-called "fear index" is so low has many, including officials at the Federal Reserve, concerned the market is complacent.

S&P 500 futures SPc1 rose 1.3 point and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures added 15 points and Nasdaq 100 futures rose 2 points.

Roughly 83,600 S&P 500 e-mini ESc1 contracts traded as of 8:20 a.m. (1100 GMT), suggesting limited action on Monday. Trading may be light until the European Central Bank'sJune 5 meeting, when many anticipate it will announce a loosening of monetary policy.

Traders are also looking ahead to data on construction spending and manufacturing. Spending is seen up 0.6 percent in April while the Institute for Supply Management's May read on manufacturing is seen rising to 55.5 from 54.9.

Ariad Pharmaceuticals Inc was one of the Nasdaq's most active premarket movers, jumping 12 percent to $7.25 in heavy volume, a day after saying its drug ponatinib showed anti-tumor activity in patients with advanced gastrointestinal stromal tumors.

Pharmacyclics Inc rose 8.4 percent to $96.30 in premarket trading after late-stage study findings showed that its drug Ibrutinib, which treats the most common form of leukemia in adults, improved survival for patients whose disease had worsened despite standard treatment. Pharmacyclics sells the drug with Johnson & Johnson.

In deal news, Japanese insurer Dai-ichi Life Co 8750.T is in advanced talks to buy Protective Life Corp in a deal that could be worth over $5 billion. Late Friday, Valeant Pharmaceuticals International Inc said it would boost its takeover bid for Allergan Inc for the second time in a week, lifting it to $53.8 billion from $49.9 billion.

Broadcom Corp shares jumped 13 percent to $35.98 on heavy premarket volume after the company said it was looking to sell or wind-down its cellular baseband business.


(Editing by Bernadette Baum)

(c) Copyright Thomson Reuters 2014. Click For Restrictions - about.reuters.com/fulllegal.asp
icon url

EZ2

07/09/14 9:49 AM

#94580 RE: **D*A** #90129

Traders are looking out to the 10-year auction and the Federal Open Market Committee minutes from the June meeting, due later in the session.

icon url

EZ2

07/27/14 6:26 PM

#95191 RE: **D*A** #90129

Just a little FYI --- for what it's worth: ie. NQ too!

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104704849
icon url

EZ2

09/11/14 6:58 AM

#96528 RE: **D*A** #90129

<< Are you watching ---- big blip since 8/1.
icon url

**D*A**

09/25/14 3:59 PM

#96792 RE: **D*A** #90129

I just went long in the American Funds, Income Fund of America with part of my cash in the 401k. The NYA50R should be close to 25%, my entry point.



icon url

conelda

10/15/14 1:20 PM

#97127 RE: **D*A** #90129

!!
icon url

EZ2

11/19/14 6:57 AM

#98497 RE: **D*A** #90129

U.S. stocks: Futures flat as investors wait for Fed minutes

MARKETWATCH 6:38 AM ET 11/19/14

Symbol Last Price Change
LOW 58.53down 0 (0%)
SPLS 12.76up 0 (0%)
LZB 22.58down 0 (0%)
JACK 71.5up 0 (0%)
TRP 49.57down 0 (0%)
QUOTES AS OF 04:03:26 PM ET 11/18/2014

By Barbara Kollmeyer, MarketWatch Staples, Lowe's(LOW) shares rise in wake of results

MADRID (MarketWatch) -- On the heels of yet another record session for major U.S. indexes, futures traded cautiously Wednesday, ahead of minutes of the latest Federal Open Market Committee meeting that could shed light on policy makers' thinking.

Upbeat results lifted shares of Lowe's Cos(LOW). and Staples Inc.(SPLS) in premarket trading.

Futures for the S&P 500 index (SPZ4) eased 1.7 points to 2,047.20, while those for the Dow Jones Industrial Average (DJZ4) dipped 9 points to 17,643. Futures for the Nasdaq-100 index (NDZ4) were up 0.5 points to 4,238.50.

On Tuesday, the S&P 500 (SPX) and the Dow industrials (DJI) managed the 43rd and 26th record closes for the year, respectively, amid the view that global central banks will stay accommodative. Biotechnology stocks were among the best performers. See Tuesday's Market Snapshot

Futures were going nowhere ahead of minutes of the Federal Reserve's Oct. 28-29 meeting, due at 2 p.m. Eastern Time. A reading on housing starts for October is due at 8:30 a.m. Eastern.

"Every nuance will be pored over, but the basic question is whether the FOMC will vote for rate hikes as long as the economic recovery continues, or only if signs of inflation appear?" said Kit Juckes, global macro strategist at Société Générale, in a note. How to read the Fed's stiff upper lip on inflation

If the current 3%-plus momentum in U.S. real GDP growth continues into 2015, Juckes believes rates will rise next year, though he notes the markets' "collective position is indecisive."

"All in all, the key will be in whether the minutes rubber-stamp the edging up in hawkishness or whether [they] will throw the doves an olive branch," said Jim Reid, strategist at Deutsche Bank, in a note.

Tuesday's data indicated strong confidence among home builders, but also revealed a surprise spike in producer prices.

Retail names report: Home improvement and office-goods retailing sectors rolled out earnings early, and so far, so good. Lowe's(LOW) shares rose 2% in premarket after the home-improvement retailer lifted its sales outlook and beat forecasts with its results.(LOW) Staples(SPLS) gained 3.7% after its earnings.Target (TGT) is also due to report ahead of the opening bell.

La-Z-Boy Inc. (LZB) could get a boost after the furniture maker beat Wall Street expectations late Tuesday. Jack in the Box Inc.(JACK) shares also rose late, on a gain in sales.

TransCanada Corp. (TRP) shares are pitching lower after the Senate last night narrowly rejected a bill to approve the construction of the company's Keystone XL oil pipeline.

Bank of Japan, Bank of England weigh in: The dollar(USDJPY) hit fresh seven-year highs against the yen, shooting past Yen117. The Bank of Japan on Wednesday stuck to maintaining its large-scale easing policy and its upbeat assessment of the economy despite downbeat economic -growth figures that prompted Prime Minister Shinzo Abe to delay a tax increase and call early elections. Read: Potential crises make the dollar the place to be

The Nikkei 225 fell 0.3% in its first chance to react since Abe announced the plans.
In the U.K., meanwhile, minutes of the Bank of England's rate-setting Monetary Policy Committee's November policy meeting hinted at deepening divisions and concerns from some members that the U.K. could overshoot its inflation target. The FTSE 100 index pulled back slightly while some European stocks managed modest gains.

Oil prices(CLZ4) remained rangebound, while gold (GCZ4) also firmed up, pushing just past $1,201.40 an ounce.

-Barbara Kollmeyer; 415-439-6400; AskNewswires@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


(END) Dow Jones Newswires
11-19-140638ET
Copyright (c) 2014 Dow Jones & Company, Inc.
icon url

EZ2

12/13/14 7:41 AM

#99650 RE: **D*A** #90129

One to watch on Monday: (a pure guesser)

JNS
icon url

EZ2

12/19/14 7:00 AM

#100018 RE: **D*A** #90129

<<~~~ Do you think we'll be re-visiting this soon? ;-)

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=99374079